Paul McGale
Contact information
Paul McGale
Medical Statistician
- Clinical Trial Service Unit
Paul is a medical statistician mainly working on case-control and cohort studies of side-effects of radiotherapy for breast cancer as well as meta-analyses of randomised trials of treatments for breast cancer. Other work has included investigations into health effects of prolonged tobacco smoking and also burden of disease caused by exposure to residential radon.
Recent publications
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
-
Twenty five year risks of breast cancer mortality in 500,000 women
Conference paper
Taylor C. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589
-
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Journal article
Henson KE. et al, (2020), Int J Cancer
-
Eligibility for Partial Breast Radiotherapy in England.
Journal article
Taylor CW. et al, (2019), Clin Oncol (R Coll Radiol)
-
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Journal article
Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)